This is not the first technology acquisition RMD has made; they have also been collaborating with Apple and Nintendo over the last 18m.
Innovation does not come without risk, but the simplest analogy here is that RMD is establishing an ecosystem not dissimilar to Apple/iTunes/iCould. As a medical professional (but mediocre investor), let me offer how difficult it is for technology to disrupt the healthcare industry. There are reasons for this, but this first-mover advantage is potentially a step-change in chronic disease management. This is not merely an incremental benefit.
You are obviously an experienced and highly analytical investor, and would already be well aware of how technology has (for example) revolutionised FMCG and pizza delivery.
Ann: ResMed to Acquire Brightree, page-5
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.28 |
Change
0.200(0.54%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $37.50 | $37.55 | $37.15 | $17.93M | 480.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3363 | $37.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.30 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
